Tokunaga, Ryuma
Graduate School of Medical Sciences,
Japan
2025 Rank: 189239
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 5814 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 189239 | 213587 |
| Total Cites | 581 | 598 |
| H-index | 10 | 10 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 334 | 338 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 334 | 338 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 558 | 570 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.05 |
| Self-Citation Percentage |
2.84%
|
|
Tokunaga, Ryuma
Kumamoto University,
Japan
2024 Rank: 165131
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 5428 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 165131 | 186987 |
| Total Cites | 587 | 598 |
| H-index | 12 | 12 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 320 | 325 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 320 | 325 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 563 | 573 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.04 |
| Self-Citation Percentage |
1.84%
|
|
Tokunaga, Ryuma
Graduate School of Medical Sciences,
Japan
2023 Rank: 167529
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 6000 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 167529 | 172553 |
| Total Cites | 609 | 653 |
| H-index | 11 | 12 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 332 | 338 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 332 | 338 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 574 | 593 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.10 |
| Self-Citation Percentage |
6.74%
|
|
Tokunaga, Ryuma
Graduate School of Medical Sciences,
Japan
2022 Rank: 136957
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 5149 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 136957 | 160340 |
| Total Cites | 599 | 617 |
| H-index | 13 | 13 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 304 | 309 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 304 | 309 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 547 | 563 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
2.92%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.